Top Markets
#1 Wrapped One Wrapped One +14,737.38%
#2 Wrapped STX (Velar) Wrapped STX (Velar) +2,972.21%
#3 Black Phoenix Black Phoenix +336.85%
#4 aPriori aPriori +110.10%
#5 Bedrock Bedrock +74.70%
#6 Cysic Cysic +48.18%
#7 Prom Prom +39.78%
#8 Playnance Playnance +35.10%
#9 COTI COTI +28.56%
#10 Nillion Nillion +23.46%
Coin of the day
Wrapped One Wrapped One
Paramètres
Langue
FRANçAIS
Devise
USD
Thème
Fresh2 Group Limited Fresh2 Group Limited

Fresh2 Group Limited

FRES
Classement en actions #42683
Fresh2 Group Limited, a biotechnology company established in New York, New... Fresh2 Group Limited, a biotechnology company established in New York, New York, in 2010, officially adopted its current name in April 2023, having previously been known as AnPac Bio-Medical Science Co., Ltd. The company is primarily engaged in the research, development, promotion, and sale of advanced multi-cancer screening and detection tests within the People's Republic of China, leveraging its proprietary cancer differentiation analysis (CDA) technology and associated devices for corporate and life insurance clients. Beyond these core diagnostic offerings, Fresh2 Group provides comprehensive physical checkup packages and an array of technology services, including market research, design, software coding, development, and testing. The company also markets genetic testing kits and various skincare products. It owns several fundamental technology platforms and actively participates in further technological innovation and product distribution. Adding a unique dimension to its operations, Fresh2 Group also manages an e-commerce platform that facilitates connections between food suppliers and both supermarket operators and restaurant owners.
Prix de l'action
$0.85
Dernière synchronisation: 2025-01-21
Capitalisation boursière
$411.40
Changement (1 jour)
0.00%
Changement (1 an)
0.00%
Pays
US
Échange Fresh2 Group Limited (FRES)

Catégorie

Healthcare
Bénéfices pour Fresh2 Group Limited (FRES)
Bénéfices en Jun 2023 TTM : $-13.66M
Selon les derniers rapports financiers de Fresh2 Group Limited, les bénéfices actuels de l'entreprise sont de $-13.66M. En 2021, l'entreprise a réalisé un bénéfice de $-18.85M, une diminution par rapport à celui de 2020 qui était de $-11.67M. Les bénéfices affichés sur cette page correspondent aux bénéfices avant intérêts et impôts, appelés aussi EBIT.
Historique des bénéfices pour Fresh2 Group Limited de 2017 à 2026
Bénéfices à la fin de chaque année
Année Bénéfices Changez
2026 (TTM) $-13.66M -10.89%
2022 $-15.33M -18.70%
2021 $-18.85M 61.55%
2020 $-11.67M -20.14%
2019 $-14.61M 130.04%
2018 $-6.35M 7.85%
2017 $-5.89M 0.00%
Bénéfices des entreprises similaires ou concurrentes
Entreprise Bénéfices Différence de bénéfices Pays
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -38,721.23%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -14,382.07%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
$3.01B -22,106.96%
BE
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
- -
KR